Sherpa Venture Capital
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Sherpa Venture Capital Information
Geographic Data
Address: No. 8 Beichen East Road
City: Beijing
State: beijing municipality
Zip: 010 100000
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfolio sources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2019 | Leto Laboratories | Series A | 3M |
| 11/2021 | Singleron Biotechnologies | Series B | 0 |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 3/2022 | Yuesai Biotechnology | Seed Round | 0 |
| 8/2020 | Zion Pharma | Series A | 20M |
| 7/2021 | Bota Biosciences | Series B | 100M |
| 12/2019 | KeChow Pharma | Series C | 45M |
| 7/2021 | Zion Pharma | Series B | 40M |
| 6/2019 | Singleron Biotechnologies | Seed Round | 14.6M |
| 6/2022 | Changjin Biotechnology | Series A | 22M |
| 12/2019 | Nanovision Technology | Series B | 22.9M |
| 5/2021 | XISOFT | Series A | 15.7M |
| 7/2021 | Hongyun Biotech | Series B | 15.4M |
| 12/2022 | Huihe Healthcare | Series C | - |
| 1/2023 | BlissBio | Series B | 14.8M |
| 10/2016 | Wag | Series B | 15M |
| 4/2022 | Shenji Bio | Series A | 47.1M |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 6/2019 | EpimAb Biotherapeutics | Series B | 74M |
| 1/2019 | Immunochina | Series C | 20.6M |
| 9/2020 | Bota Biosciences | Series A | 15M |
| 7/2021 | Neukio Biotherapeutics | Angel Round | 40M |
| 11/2021 | BAKX Therapeutics | Series A | 25M |
| 9/2022 | Insight Lifetech | Series D | - |
| 8/2021 | CashBackMobileApp | Pre Seed Round | 475k |
| 9/2021 | Vision X | Series B | - |
| 9/2019 | GKHT Medical Technology | Series C | 154.5M |
| 12/2019 | Hui-Gene Therapeutics | Series A | 14.2M |
| 7/2021 | Jyss Bio | Series B | - |
| 5/2021 | Alebund Pharmaceuticals | Series B | 0 |
| 7/2021 | PAQ Therapeutics | Series A | 0 |
| 3/2021 | Jianhai Technology | Series B | 23M |
| 7/2019 | Jianhai Technology | Series A | 14.6M |
| 2/2020 | Hongyun Biotech | Series A | 7.2M |
| 7/2019 | Joinhealth Technology | Series A | 14.6M |
| 5/2022 | Hui-Gene Therapeutics | Series C | - |
| 5/2021 | Appia Bio | Series A | 52M |
| 12/2014 | Mattermark | Series A | 0 |
| 6/2021 | HiFiBiO | Series D | 0 |
| 7/2022 | ClinChoice昆翎 | Series E | 0 |
| 9/2021 | Alebund Pharmaceuticals | Series B | 0 |
| 12/2021 | Pilot Biotechnology | Series C | - |
| 4/2021 | Brattea | Series B | 20M |
| 5/2021 | MindRank AI | Seed Round | 7M |
| 9/2020 | Jianhai Technology | Series A | 8.8M |
| 6/2018 | Hongyun Biotech | Angel Round | 3.1M |
| 1/2019 | Yosemite Clinic | Series B | 14.9M |
| 4/2021 | EdiGene | Series B | 61.6M |
| 3/2022 | UniXell | Seed Round | 0 |
| 7/2021 | MAXVAX | Series A | - |
| 11/2021 | Fuse Biotherapeutics | Seed | 9.5M |
| 12/2021 | Starna Therapeutics | Angel Round | 10M |
| 6/2022 | Yuanyin Bio | Series A | 0 |
| 12/2021 | MindRank AI | Series A | 19M |
| 5/2019 | New Horizon Health | Series C | 0 |
| 1/2021 | Visen Pharmaceuticals | Series B | 0 |
| 9/2022 | Neukio Biotherapeutics | Series A | 50M |
| 11/2021 | Sepax Technologies | Series D | 0 |
| 11/2021 | Wuxi Biortus Biosciences | Series B | 31.3M |
| 6/2022 | Raykol | Series A | 14.8M |
| 5/2022 | Ketai Bio | Series A | 14.9M |
| 3/2021 | EpimAb Biotherapeutics | Series C | 0 |
| 7/2022 | ClinChoice昆翎 | Series E | 0 |
| 6/2022 | Yuanyin Bio | Series A | 0 |
| 6/2022 | Raykol | Series A | 0 |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 5/2022 | Hui-Gene Therapeutics | Series C | - |
| 4/2022 | Shenji Bio | Series A | 0 |
| 3/2022 | UniXell | Seed Round | 0 |
| 3/2022 | Yuesai Biotechnology | Seed Round | 0 |
| 12/2021 | Pilot Biotechnology | Series C | - |
| 12/2021 | MindRank AI | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
